You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

App icon
FreshPublishers
Open in the app
OPEN

HYTN successfully exports cannabis vape cartridges to Australia

HYTN Innovations has announced the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia's regulated medical cannabis market.

The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN's GMP quality systems, these market-ready cartridges demonstrate HYTN's capability to supply finished non-sterile cannabis oil products in a market-ready format for international regulated distribution.

This achievement follows a successful Health Canada a compliant rated inspection exit notice that expanded the Company's Drug Establishment Licence (DEL) to include oil as both an active pharmaceutical ingredient (API) and a finished dosage form. These enhancements bolster HYTN's GMP platform, enabling the production and export of oil-based cannabis products in both API and finished formats for regulated medical markets including Germany, the United Kingdom, and Australia.

"The successful release of GMP finished vape cartridges is an important operational milestone for HYTN," said Jason Broome, Chief Operating Officer of HYTN. "This was a full commercial batch – not bulk extract or a development run. These one-gram live resin cartridges were manufactured under GMP as finished goods and have now been released for supply into the Australian market by HYTN. Combined with our expanded DEL scope, this significantly broadens the product formats and services we can deliver to regulated international markets."

The release builds on HYTN's earlier international vape cartridge development work, including its ongoing GMP stability program, cartridge validation activities, and prior purchase orders. It further validates HYTN's ability to progress product from development and validation through to full GMP manufacturing, export and regulated market release.

HYTN will continue to evaluate future oil-based product opportunities on a case-by-case basis, considering product specifications, quality standards, importer needs, market release procedures, commercial terms, and local regulatory requirements.

For more information:
HYTN Innovations
hytn.ca/

Related Articles → See More